Splenectomy can achieve a complete remission in about two thirds of patients who relapse after initial corticosteroid therapy. Splenectomy is usually reserved for patients with severe thrombocytopenia (eg, < 15, 000 / mcL [< 15 × 10 9 / L]) in whom bleeding risk cannot be controlled with medical therapy or those whose disease persists after 12 months.